Skip to main content

Table 4 Mean IC 50 values of drugs grouped according to histopathological categories and previous treatment in the CRC subgroup

From: Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer

Drugs

Prior Chemotherapy

Lymph node

Mucinous

Tumour differentiation

Signet cell

n=49ā€ 

Yes

No

Pos

Neg

Yes

No

Poor

Moderate

Well

Yes

No

Ā 

n=39

n=10

n=37

n=12

n=29

n=20

n=19

n=24

n=6

n=6

n=43

Oxa

31.7

30.1 (0.9)

31.0

32.4 (0.9)

36.9

22.6 (0.1)

34.7

23.9 (0.5)

35.3

29.1

31.6 (0.9)

Cis

21.6

26.2 (0.6)

20.1

23.8 (0.9)

29.7

13.6 (0.05)

23.3

17.0 (0.4)

32.8

13.7

24.7 (0.4)

Mel

53.3

52.2 (0.9)

56.1

53.1 (0.8)

52.4

53.8 (0.9)

49.1

53.3 (0.9)

54.8

44.2

52.9 (0.5)

5-FU

539.5

475.4 (0.6)

497.5

604.9 (0.4)

542.1

455.5 (0.4)

521.5

426.6 (0.3)

689.9

490.4

519.2 (0.9)

MMC

19.1

22.5 (0.7)

23.3

12.0 (0.3)

24.6

14.2 (0.2)

12.8

20.5 (0.4)

29.4

8.68

21.2 (0.3)

Iri

131.7

163.1 (0.6)

153.3

111.2 (0.5)

183.9

81.1 (0.07)

122.0

163.5 (0.8)

129.2

84.4

151.6 (0.5)

Doce

15.0

21.5 (0.3)

18.5

13.8 (0.4)

17.2

16.6 (0.9)

16.9

17.9 (0.8)

12.4

23.5

14.4 (0.1)

Dox

2.80

2.98 (0.9)

3.34

1.59 (0.1)

2.96

2.78 (0.9)

1.74

3.51 (0.3)

2.86

1.20

2.96 (0.3)

  1. Numbers in parentheses represent p-values from a Student t-test with the exception of tumor grading which was calculated with a one-way ANOVA.
  2. ā€  Missing histopathological data in 3 patients.
  3. Abbreviations: Pos positive, Neg negative, Oxa oxaliplatin, Cis cisplatin, 5-FU 5-fluorouracil, MMC mitomycin C, Iri irinotecan, Doce docetaxel, Dox doxorubicin.